Pheochromocytomas Withdrawn Phase 1 / 2 Trials for Lutetium Lu 177 dotatate (DB13985)

Also known as: Pheochromocytoma / Chromaffin cell neoplasm (morphologic abnormality) / Phaeochromocytoma / Pheochromocytoma (morphologic abnormality) / Phaeochromocytoma [Ambiguous]

IndicationStatusPhase
DBCOND0071316 (Pheochromocytomas)Withdrawn1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03923257Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and AdolescentsTreatment